Immunoglobulin A deficiency following treatment with lamotrigine
- 1 November 2016
- journal article
- case report
- Published by Elsevier in Brain and Development
- Vol. 38 (10) , 947-949
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepineActa Neurologica Scandinavica, 2012
- Valproate-induced panhypogammaglobulinemiaNeurological Sciences, 2012
- Carbamazepine-induced hypogammaglobulinemiaSeizure: European Journal of Epilepsy, 2012
- Oral hairy leukoplakia in a patient on long-term anticonvulsant treatment with lamotrigineOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2011
- REVERSIBLE PANHYPOGAMMAGLOBULINEMIA ASSOCIATED WITH THE ANTIEPILEPTIC AGENT LEVETIRACETAMAnnals of Allergy, Asthma & Immunology, 2008
- Lamotrigine-induced common variable immune deficiencyNeurology, 2004
- IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatmentEuropean Journal of Pediatrics, 2003
- IgA and IgG2 Deficiency Associated with Zonisamide Therapy: A Case ReportEpilepsia, 1997
- IgA DEFICIENCY, EPILEPSY, AND PHENYTOIN TREATMENTThe Lancet, 1975